Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Preclinical profile of Co-102862 presented at neuroscience congress

Dec. 3, 1997

Imitrex Nasal Spray now available in U.S.

Dec. 2, 1997

Long-lasting effects on memory impairment of M2 antagonist treatment in rats

Dec. 2, 1997

Potent antiamnesia activity reported for AChE inhibitor DHED

Dec. 2, 1997

Anticonvulsant activity of retigabine established in preclinical model

Dec. 2, 1997

Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS

Dec. 2, 1997

Dopamine receptor subtype-specific ligands prepared at Neurogen

Dec. 2, 1997

Fujisawa isolates novel calpain inhibitors

Dec. 2, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Effects of AE-0047 on cerebral ischemia/edema and renal injury

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...